Skip to main content

Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) Investor Files Lawsuit Against Buyout By Mallinckrodt plc

  • If you purchased shares of Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) and currently hold any of those NASDAQ:CADX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 21, 2014 (Shareholders Foundation) - An investor who currently holds shares of Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) filed a lawsuit in effort to halt the proposed takeover of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc for $14.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CADX stockholders arising out of t...



You must register (for free) or login to view the entire case.